167 related articles for article (PubMed ID: 20130206)
1. Excitation-contraction coupling alterations in mdx and utrophin/dystrophin double knockout mice: a comparative study.
Capote J; DiFranco M; Vergara JL
Am J Physiol Cell Physiol; 2010 May; 298(5):C1077-86. PubMed ID: 20130206
[TBL] [Abstract][Full Text] [Related]
2. The role of proteases in excitation-contraction coupling failure in muscular dystrophy.
Mázala DA; Grange RW; Chin ER
Am J Physiol Cell Physiol; 2015 Jan; 308(1):C33-40. PubMed ID: 25298424
[TBL] [Abstract][Full Text] [Related]
3. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.
Baker PE; Kearney JA; Gong B; Merriam AP; Kuhn DE; Porter JD; Rafael-Fortney JA
Neurogenetics; 2006 May; 7(2):81-91. PubMed ID: 16525850
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
[TBL] [Abstract][Full Text] [Related]
6. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.
van Putten M; Kumar D; Hulsker M; Hoogaars WM; Plomp JJ; van Opstal A; van Iterson M; Admiraal P; van Ommen GJ; 't Hoen PA; Aartsma-Rus A
Neuromuscul Disord; 2012 May; 22(5):406-17. PubMed ID: 22284942
[TBL] [Abstract][Full Text] [Related]
7. C-terminal-truncated microdystrophin recruits dystrobrevin and syntrophin to the dystrophin-associated glycoprotein complex and reduces muscular dystrophy in symptomatic utrophin/dystrophin double-knockout mice.
Yue Y; Liu M; Duan D
Mol Ther; 2006 Jul; 14(1):79-87. PubMed ID: 16563874
[TBL] [Abstract][Full Text] [Related]
8. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
9. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of brain utrophin does not rescue behavioral alterations in dystrophin-deficient mice.
Perronnet C; Chagneau C; Le Blanc P; Samson-Desvignes N; Mornet D; Laroche S; De La Porte S; Vaillend C
Hum Mol Genet; 2012 May; 21(10):2263-76. PubMed ID: 22343141
[TBL] [Abstract][Full Text] [Related]
11. Variable cytoplasmic actin expression impacts the sensitivity of different dystrophin-deficient mdx skeletal muscles to eccentric contraction.
Lindsay A; Southern WM; McCourt PM; Larson AA; Hodges JS; Lowe DA; Ervasti JM
FEBS J; 2019 Jul; 286(13):2562-2576. PubMed ID: 30942954
[TBL] [Abstract][Full Text] [Related]
12. [Mesenchymal stem cells transplanted in mdx mice differentiate into myocytes and express dystrophin/utrophin].
Feng SW; Zhang C; Lu XL; Liu TY; Li CM; Yao XL; Yu MJ
Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):974-8. PubMed ID: 19460724
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
[TBL] [Abstract][Full Text] [Related]
14. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
[TBL] [Abstract][Full Text] [Related]
15. The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice.
Di Certo MG; Corbi N; Strimpakos G; Onori A; Luvisetto S; Severini C; Guglielmotti A; Batassa EM; Pisani C; Floridi A; Benassi B; Fanciulli M; Magrelli A; Mattei E; Passananti C
Hum Mol Genet; 2010 Mar; 19(5):752-60. PubMed ID: 19965907
[TBL] [Abstract][Full Text] [Related]
16. TAT-μUtrophin mitigates the pathophysiology of dystrophin and utrophin double-knockout mice.
Call JA; Ervasti JM; Lowe DA
J Appl Physiol (1985); 2011 Jul; 111(1):200-5. PubMed ID: 21565990
[TBL] [Abstract][Full Text] [Related]
17. Social stress is lethal in the mdx model of Duchenne muscular dystrophy.
Razzoli M; Lindsay A; Law ML; Chamberlain CM; Southern WM; Berg M; Osborn J; Engeland WC; Metzger JM; Ervasti JM; Bartolomucci A
EBioMedicine; 2020 May; 55():102700. PubMed ID: 32192914
[TBL] [Abstract][Full Text] [Related]
18. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
Ito M; Ehara Y; Li J; Inada K; Ohno K
Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
[TBL] [Abstract][Full Text] [Related]
19. Depolarization-induced contraction and SR function in mechanically skinned muscle fibers from dystrophic mdx mice.
Plant DR; Lynch GS
Am J Physiol Cell Physiol; 2003 Sep; 285(3):C522-8. PubMed ID: 12724137
[TBL] [Abstract][Full Text] [Related]
20. Functional substitution by TAT-utrophin in dystrophin-deficient mice.
Sonnemann KJ; Heun-Johnson H; Turner AJ; Baltgalvis KA; Lowe DA; Ervasti JM
PLoS Med; 2009 May; 6(5):e1000083. PubMed ID: 19478831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
